Search Results - "Demichelis, Roberta"
-
1
Splenectomy outcomes in patients with autoimmune cytopenias and persistent antiphospholipid antibodies
Published in Transfusion (Philadelphia, Pa.) (01-12-2022)“…Background Splenectomy is a therapy for patients with treatment‐refractory autoimmune cytopenias. Antiphospholipid antibodies (aPL) can be identified in…”
Get full text
Journal Article -
2
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
Published in American journal of hematology (01-09-2024)“…Crovalimab is a novel C5 complement inhibitor that enables rapid and sustained C5 inhibition with subcutaneous, low‐volume self‐administration every 4 weeks…”
Get full text
Journal Article -
3
Acute myeloid leukemia: challenges for diagnosis and treatment in Latin America
Published in Hematology (Luxembourg) (31-12-2023)“…to review the current diagnostic and therapeutic landscape of AML in Latin America as a reflection of other low- and middle-income countries and regions of the…”
Get full text
Journal Article -
4
Is iron overload associated with worse outcomes in patients with chronic liver disease undergoing liver transplantation?
Published in Revista de investigacion clinica (01-03-2024)“…Iron overload is frequent in patients with chronic liver disease, associated with shorter survival after liver transplantation in patients with hereditary…”
Get full text
Journal Article -
5
Are delays in diagnosis and treatment of acute leukemia in a middle-income country associated with poor outcomes? A retrospective cohort study
Published in Hematology, Transfusion and Cell Therapy (01-10-2024)“…Acute leukemias (ALs) are aggressive diseases that lead to death without medical attention. We evaluated the association between delays in diagnosis and poor…”
Get full text
Journal Article -
6
A phase III, randomised, double‐blind, multi‐national clinical trial comparing SB12 (proposed eculizumab biosimilar) and reference eculizumab in patients with paroxysmal nocturnal haemoglobinuria
Published in EJHaem (01-02-2023)“…Treatment of paroxysmal nocturnal haemoglobinuria (PNH) includes the monoclonal antibody eculizumab. This randomised, double‐blind, multi‐national cross‐over…”
Get full text
Journal Article -
7
PB2627: THROMBOTIC THROMBOCYTOPENIC PURPURA, RELAPSE RELATED RISK FACTORS IN A CARE CENTER WITH LIMITED ACCESS TO ADAMTS13 LEVELS
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
8
P1664: WHICH FACTORS DO IMPACT IN OPTIMAL ANTICOAGULATION IN ANTIPHOSPHOLIPID SYNDROME?
Published in HemaSphere (08-08-2023)Get full text
Journal Article -
9
Effectiveness of L-asparaginase-based regimens compared to anthracycline-based regimens in newly diagnosed extranodal NK/T-cell lymphoma, nasal type: a single Mexican center experience
Published in Blood research (01-09-2018)“…Extranodal NK/T-cell lymphoma, nasal type (ENKTCL) has a high prevalence in Asia and Latin American countries, such as Mexico, where it encompasses 40% of all…”
Get full text
Journal Article -
10
Cost-effectiveness of the regimen proposed by the International Consortium on Acute Promyelocytic Leukemia for the treatment of newly diagnosed patients with Acute Promyelocytic Leukemia
Published in Hematology, Transfusion and Cell Therapy (01-10-2021)“…INTRODUCTIONWe performed cost-effectiveness and cost-utility analyses of the modified International Consortium on Acute Promyelocytic Leukemia protocol in…”
Get full text
Journal Article -
11
-
12
Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases
Published in Blood research (01-06-2019)“…infection (CDI) is a nosocomial condition prevalent in patients with hematological disorders. We aimed to identify the risk factors associated with the…”
Get full text
Journal Article -
13
Prognostic Effect of CD20 Expression in Adult B-cell Acute Lymphoblastic Leukemia
Published in Clinical lymphoma, myeloma and leukemia (01-05-2018)“…Expression of CD20 in adult B-cell acute lymphoblastic leukemia has been associated with a poor prognosis. Previous studies have suggested treatment with…”
Get full text
Journal Article -
14
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions
Published in Current oncology reports (06-10-2020)“…Purpose of Review Acute myeloid leukemia (AML) is a costly disease, and its impact is greater in developing countries (DC). We will review the current concept…”
Get full text
Journal Article -
15
Induction-related mortality in adolescents and young adults with acute lymphoblastic leukemia in a resource-limited setting: do treatment-related complications create more impact than disease biology?
Published in Blood research (31-03-2022)“…Acute lymphoblastic leukemia (ALL) is a malignant clonal bone marrow disorder with a high mortality rate during the initial therapy. This retrospective study…”
Get full text
Journal Article -
16
Venetoclax-based combinations for acute myeloid leukemia: optimizing their use in Latin-America
Published in Hematology (Luxembourg) (31-12-2022)“…Objectives: Venetoclax combinations are a new standard for patients with acute myeloid leukemia (AML). We aimed to evaluate the safety and efficacy of these…”
Get full text
Journal Article -
17
Description of therapeutic strategies in severe systemic lupus erythematosus-associated immune thrombocytopenia: a retrospective cohort study of response and relapse
Published in Clinical rheumatology (01-08-2024)“…Objectives To describe the response and relapse of severe thrombocytopenia in patients with systemic lupus erythematosus (SLE) with different treatments…”
Get full text
Journal Article -
18
Tumor Lysis Syndrome Is Associated with Worse Outcomes in Adult Patients with Acute Lymphoblastic Leukemia
Published in Acta haematologica (2024)“…Tumor lysis syndrome (TLS) occurs frequently during induction therapy for acute lymphoblastic leukemia (ALL). Patients are categorized into intermediate- or…”
Get more information
Journal Article -
19
Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used
Published in Blood research (01-12-2016)“…Different criteria have been used to diagnose mixed-phenotype acute leukemia (MPAL), which has impacted the number of individuals diagnosed with this…”
Get full text
Journal Article -
20
Circulating HMGB1 is increased in myelodysplastic syndrome but not in other bone marrow failure syndromes: proof-of-concept cross-sectional study
Published in Therapeutic advances in hematology (2022)“…Background: Myelodysplastic syndrome (MDS) is associated with persistent immune activation. High mobility group box-1 (HMGB1) is a ubiquitous, functionally…”
Get full text
Journal Article